Results 91 to 100 of about 32,649 (166)

CD20-Targeted α-Radionuclides Synergize with Immune Checkpoint Inhibition to Treat Murine Lymphoma. [PDF]

open access: yesJ Nucl Med
O'Steen S   +14 more
europepmc   +1 more source

Antibody-dependent cellular phagocytosis in cancer immunotherapy: research and perspectives. [PDF]

open access: yesJ Transl Med
Gu Q   +9 more
europepmc   +1 more source

Integrating B Cell Differentiation Model With Real-World Data Informs Determinants for Antibody-Secreting Cell Depletions in Systemic Sclerosis. [PDF]

open access: yesCPT Pharmacometrics Syst Pharmacol
Nakada T   +8 more
europepmc   +1 more source

CD20<sup>+</sup>FCRL4<sup>+</sup> B Cells Activate CD8<sup>+</sup> T Cells via MHC-I Restriction in Nasopharyngeal Carcinoma Anti-Tumor Immunity. [PDF]

open access: yesAdv Sci (Weinh)
Zhang B   +17 more
europepmc   +1 more source

Harnessing the power of natural killer cells in Lymphoma immunotherapy: Overcoming challenges and enhancing treatment options. [PDF]

open access: yesHematol Transfus Cell Ther
Roshandel E   +7 more
europepmc   +1 more source

Lymph node microenvironment remodeling unlocks local antibody-mediated B cell depletion. [PDF]

open access: yesSci Adv
Garcia Z   +11 more
europepmc   +1 more source

Molecular Mechanisms of Resistance to Bispecific Antibodies in Diffuse Large B-Cell Lymphoma. [PDF]

open access: yesCells
Maher N   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy